Rocket Pharmaceuticals (NASDAQ:RCKT – Get Free Report) was upgraded by research analysts at Needham & Company LLC from a “hold” rating to a “buy” rating in a research note issued to investors on Wednesday, MarketBeat reports. The firm presently has a $9.00 target price on the biotechnology company’s stock. Needham & Company LLC’s price target […]

Definium Therapeutics (NASDAQ:DFTX – Get Free Report)‘s stock had its “buy” rating restated by investment analysts at Needham & Company LLC in a research report issued on Monday, Benzinga reports. They presently have a $66.00 price target on the stock. Needham & Company LLC’s price objective would suggest a potential upside of 69.71% from the […]

Ionis Pharmaceuticals (NASDAQ:IONS – Get Free Report)‘s stock had its “buy” rating restated by analysts at Needham & Company LLC in a report issued on Friday, Benzinga reports. They currently have a $86.00 price target on the stock. Needham & Company LLC’s price target would suggest a potential upside of 46.97% from the stock’s current […]